Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: Potential involvement in early control of viral replication

Journal of Infectious Diseases

Volumn 195, Issue 8, 2007, Pages 1108-1116

  Laoprasopwattana, Kamolwish ^a,c   Libraty, Daniel H ^a   Endy, Timothy P ^b,f   Nisalak, Ananda ^d   Chunsuttiwat, Supamit ^e   Ennis, Francis A ^a   Rothman, Alan L ^a   Green, Sharone ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^d ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^e MINISTRY OF PUBLIC HEALTH   (Thailand)

^f SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; IMMUNOGLOBULIN G1; NEUTRALIZING ANTIBODY;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DENGUE; DISEASE SEVERITY; HUMAN; HUMAN CELL; INFECTION CONTROL; MAJOR CLINICAL STUDY; PLASMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAJI CELL; REINFECTION; SCHOOL CHILD; THAILAND; VIREMIA; VIRUS IMMUNITY; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CHILD; COHORT STUDIES; DENGUE; DENGUE VIRUS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HOSPITALIZATION; HUMANS; IMMUNOGLOBULIN G; KILLER CELLS, NATURAL; PROSPECTIVE STUDIES; RECURRENCE; SEROTYPING; STATISTICS; VIREMIA; VIRUS REPLICATION;

EID: 34047221846     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/512860     Document Type: Article

References (44)

1. Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev 1990;3:376-96.
2. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002; 10:100-3.
3. Sabin AB. Research on dengue during World War II. Am J Trop Med Hyg 1952; 1:30-50.
4. Laoprasopwattana K, Libraty DH, Endy TP, et al. Dengue virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection. J Infect Dis 2005; 192:510-9.
5. Endy TP, Nisalak A, Chunsuttitwat S, et al. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 2004; 189:990-1000.
6. Khyatti M, Ahmad A, Blagdon M, Frade R, Menezes J. Binding of the endogenously expressed Epstein-Barr virus (EBV) envelope glycoprotein gp350 with the viral receptor masks the major EBV-neutralizing epitope and affects gp350-specifk ADCC. J Leukoc Biol 1998; 64:192-7.
7. Tanner JE, Wei MX, Alfieri C, et al. Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders. J Infect Dis 1997; 175:38-46.
8. Ahmad R, Sindhu ST, Toma E, et al. Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection. J Clin Immunol 2001; 21:227-33.
9. Broliden K, Sievers E, Tovo PA, et al. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children. Clin Exp Immunol 1993; 93:56-64.
10. Forthal DN, Landucci G, Daar ES. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. J Virol 2001; 75:6953-61.
11. Yamada T, Watanabe N, Nakamura T, Iwamoto A. Antibody-dependent cellular cytotoxicity via humoral immune epitope of Nef protein expressed on cell surface. J Immunol 2004; 172:2401-6.
12. Nattermann J, Schneiders AM, Leifeld L, et al. Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC). J Hepatol 2005; 42:499-504.
13. Kohl S, Charlebois ED, Sigouroudinia M, et al. Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine. J Infect Dis 2000; 181:335-9.
14. Hashimoto G, Wright PF, Karzon DT. Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J Infect Dis 1983; 148:785-94.
15. Gomez-Roman VR, Patterson LJ, Venzon D, et al. Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J Immunol 2005; 174:2185-9.
16. Kurane I, Hebblewaite D, Brandt WE, Ennis FA. Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Virol 1984; 52:223-30.
17. Shresta S, Kyle JL, Robert Beatty P, Harris E. Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology 2004; 319:262-73.
18. Green S, Pichyangkul S, Vaughn DW, et al. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis 1999; 180:1429-35.
19. Azeredo EL, De Oliveira-Pinto LM, Zagne SM, Cerqueira DI, Nogueira RM, Kubelka CF. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin Exp Immunol 2006; 143:345-56.
20. Endy TP, Chunsuttiwat S, Nisalak A, et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002; 156:40-51.
21. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181:2-9.
22. Endy TP, Nisalak A, Chunsuttiwat S, et al. Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002; 156:52-9.
23. Houng HS, Chung-Ming Chen R, Vaughn DW, Kanesa-thasan N. Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3′ noncoding sequences. J Virol Methods 2001; 95:19-32.
24. Innis BL, Nisalak A, Nimmannitya S, et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 1989; 40:418-27.
25. Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958; 7:561-73.
26. Rosen L. The use of Toxorhynchites mosquitoes to detect and propagate dengue and other arboviruses. Am J Trop Med Hyg 1981; 30:177-83.
27. Waterman SH, Kuno G, Gubler DJ, Sather GE. Low rates of antigen detection and virus isolation from the peripheral blood leukocytes of dengue fever patients. Am J Trop Med Hyg 1985; 34:380-4.
28. Watanaveeradej V, Endy TP, Samakoses R, et al. Transplacentally transferred maternal-infant antibodies to dengue virus. Am J Trop Med Hyg 2003;69:123-8.
29. Russell PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 1967; 99:285-90.
30. Rozsnyay Z, Sarmay G, Walker M, et al. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions. Immunology 1989; 66:491-8.
31. Galatiuc C, Gherman M, Metes D, et al. Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies. Cell Immunol 1995; 163:167-77.
32. Choi SS, Chhabra VS, Nguyen QH, Ank BJ, Stiehm ER, Roberts RL. Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture. Clin Diagn Lab Immunol 2004; 11:879-88.
33. Vankayalapati R, Wizel B, Weis SE, et al. The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2002; 168:3451-7.
34. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23:225-74.
35. Lobigs M, Blanden RV, Mullbacher A. Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity. Immunol Rev 1996; 152:5-19.
36. Mullbacher A, Lobigs M. Up-regulation of MHC class I by flavivirus-induced peptide translocation into the endoplasmic reticulum. Immunity 1995; 3:207-14.
37. Lobigs M, Mullbacher A, Lee E. Evidence that a mechanism for efficient flavivirus budding upregulates MHC class I. Immunol Cell Biol 2004; 82:184-8.
38. Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol 2001; 75:3501-8.
39. Wu SJ, Grouard-Vogel G, Sun W, et al. Human skin Langerhans cells are targets of dengue virus infection. Nat Med 2000;6:816-20.
40. Palucka AK. Dengue virus and dendritic cells. Nat Med 2000; 6:748-9.
41. Green S, Vaughn DW, Kalayanarooj S, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999; 179:755-62.
42. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Ennis FA. High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg 1993; 48:222-9.
43. Garcia G, Arango M, Pérez AB, et al. Antibodies from patients with dengue viral infection mediate cellular cytotoxicity. J Clin Virol 2006; 37:53-7.
44. Hezareh M, Hessell AJ, Jensen RC, van de Winkel JG, Parren PW. Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1. J Virol 2001; 75:12161-8.